Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1982 1
1983 1
1985 1
1987 1
1989 1
1996 1
1998 1
1999 2
2000 2
2001 4
2002 5
2003 2
2004 9
2005 9
2006 17
2007 4
2008 19
2009 14
2010 12
2011 21
2012 15
2013 21
2014 19
2015 29
2016 23
2017 24
2018 28
2019 38
2020 42
2021 38
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

387 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiome: Profound Implications for Diet and Disease.
Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Hills RD Jr, et al. Nutrients. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613. Nutrients. 2019. PMID: 31315227 Free PMC article. Review.
Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g., Bifidobacterium, Akkermansia) versus facultative anaerobes (E. coli), pro-inflammatory Rumin …
Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the …
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
Chlebicz-Wójcik A, Śliżewska K. Chlebicz-Wójcik A, et al. Biomolecules. 2021 Aug 4;11(8):1154. doi: 10.3390/biom11081154. Biomolecules. 2021. PMID: 34439821 Free PMC article. Review.
Irritable bowel syndrome is not a life-threatening disease, yet it significantly affects the quality of life and contributes to economic loss. ...The aim of this review was to summarize findings on the usefulness of probiotics, prebiotics, and synbiotics in t
Irritable bowel syndrome is not a life-threatening disease, yet it significantly affects the quality of life and contri
Gut microbiota and its mysteries.
Pushpanathan P, Mathew GS, Selvarajan S, Seshadri KG, Srikanth P. Pushpanathan P, et al. Indian J Med Microbiol. 2019 Apr-Jun;37(2):268-277. doi: 10.4103/ijmm.IJMM_19_373. Indian J Med Microbiol. 2019. PMID: 31745030 Free article. Review.
Gut microbiota are microorganisms that inhabit the gut; they coexist peacefully with the host, thereby contributing to the health and well-being of individuals. Bacteroidetes and Firmicutes largely dominate the gut microbial flora. The intestinal flora promotes intestinal …
Gut microbiota are microorganisms that inhabit the gut; they coexist peacefully with the host, thereby contributing to the health and well-b …
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Lyra A, et al. World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631. World J Gastroenterol. 2016. PMID: 28082816 Free PMC article. Clinical Trial.
AIM: To determine the effects of Lactobacillus acidophilus NCFM on irritable bowel syndrome (IBS) symptoms and quality of life (QoL). ...
AIM: To determine the effects of Lactobacillus acidophilus NCFM on irritable bowel syndrome (IBS) symptoms and quality …
A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.
Peter J, Fournier C, Durdevic M, Knoblich L, Keip B, Dejaco C, Trauner M, Moser G. Peter J, et al. Psychosom Med. 2018 Oct;80(8):698-709. doi: 10.1097/PSY.0000000000000630. Psychosom Med. 2018. PMID: 30095672 Free PMC article. Clinical Trial.
OBJECTIVE: Irritable bowel syndrome (IBS) is associated with alterations along the brain-gut-microbiota axis. ...
OBJECTIVE: Irritable bowel syndrome (IBS) is associated with alterations along the brain-gut-microbiota axis. ...
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.
Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Pittayanon R, et al. Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30. Gastroenterology. 2019. PMID: 30940523
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has been proposed as a strategy for treatment of IBS, but the association between the gut microbiome and IBS symptoms has not been well establi …
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has …
The gut microbiome.
Sidhu M, van der Poorten D. Sidhu M, et al. Aust Fam Physician. 2017;46(4):206-211. Aust Fam Physician. 2017. PMID: 28376573 Free article.
OBJECTIVE: This article provides an overview of the gut microbiome in health and disease, highlighting conditions such as Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, obesity and non-alcoholic fatty liver disea …
OBJECTIVE: This article provides an overview of the gut microbiome in health and disease, highlighting conditions such as Clostridium diffic …
Thirty Years of Lactobacillus rhamnosus GG: A Review.
Capurso L. Capurso L. J Clin Gastroenterol. 2019 Mar;53 Suppl 1:S1-S41. doi: 10.1097/MCG.0000000000001170. J Clin Gastroenterol. 2019. PMID: 30741841 Review.
The effectiveness of LGG in gastrointestinal infections and diarrhea, antibiotic and Clostridium difficile associated diarrhea, irritable bowel syndrome, inflammatory bowel disease, respiratory tract infections, allergy, cardiovascular diseases, nonalc …
The effectiveness of LGG in gastrointestinal infections and diarrhea, antibiotic and Clostridium difficile associated diarrhea, irritable
Bacillus coagulans and its applications in medicine.
Mu Y, Cong Y. Mu Y, et al. Benef Microbes. 2019 Jul 10;10(6):679-688. doi: 10.3920/BM2019.0016. Epub 2019 Jun 17. Benef Microbes. 2019. PMID: 31203635 Review.
Recent studies have shown that B. coagulans has therapeutic effects on intestinal diseases, such as acute diarrhoea, irritable bowel syndrome, antibiotic-related diarrhoea, constipation and colitis via modulation of the microbiota composition, host immunity a …
Recent studies have shown that B. coagulans has therapeutic effects on intestinal diseases, such as acute diarrhoea, irritable bow
A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome.
Zhao L, Yang W, Chen Y, Huang F, Lu L, Lin C, Huang T, Ning Z, Zhai L, Zhong LL, Lam W, Yang Z, Zhang X, Cheng C, Han L, Qiu Q, Shang X, Huang R, Xiao H, Ren Z, Chen D, Sun S, El-Nezami H, Cai Z, Lu A, Fang X, Jia W, Bian Z. Zhao L, et al. J Clin Invest. 2020 Jan 2;130(1):438-450. doi: 10.1172/JCI130976. J Clin Invest. 2020. PMID: 31815740 Free PMC article. Clinical Trial.
An excess of fecal bile acids (BAs) is thought to be one of the mechanisms for diarrhea-predominant irritable bowel syndrome (IBS-D). However, the factors causing excessive BA excretion remain incompletely studied. ...
An excess of fecal bile acids (BAs) is thought to be one of the mechanisms for diarrhea-predominant irritable bowel syndrom
387 results